Unknown

Dataset Information

0

The Clinical Application of Neoantigens in Esophageal Cancer.


ABSTRACT: Esophageal cancer (EC) is a common malignant tumor with poor prognosis, and current treatments for patients with advanced EC remain unsatisfactory. Recently, immunotherapy has been recognized as a new and promising approach for various tumors. EC cells present a high tumor mutation burden and harbor abundant tumor antigens, including tumor-associated antigens and tumor-specific antigens. The latter, also referred to as neoantigens, are immunogenic mutated peptides presented by major histocompatibility complex class I molecules. While current genomics and bioinformatics technologies have greatly facilitated the identification of tumor neoantigens, identifying individual neoantigens systematically for successful therapies remains a challenging problem. Owing to the initiation of strong, specific tumor-killing cytotoxic T cell responses, neoantigens are emerging as promising targets to develop personalized treatment and have triggered the development of cancer vaccines, adoptive T cell therapies, and combination therapies. This review aims to give a current understanding of the clinical application of neoantigens in EC and provide direction for future investigation.

SUBMITTER: Gu YM 

PROVIDER: S-EPMC8353328 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8630679 | biostudies-literature
| S-EPMC8317330 | biostudies-literature
| S-EPMC6529170 | biostudies-literature
| S-EPMC6731555 | biostudies-literature
| S-EPMC6693295 | biostudies-literature
| S-EPMC5591441 | biostudies-literature
| S-EPMC6422802 | biostudies-other
| S-EPMC5655197 | biostudies-other
| S-EPMC8576729 | biostudies-literature
| S-EPMC5748868 | biostudies-literature